{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:39:58Z","timestamp":1790127598425,"version":"4.0.1"},"reference-count":200,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-15-0217"],"award-info":[{"award-number":["APVV-15-0217"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-16-0021"],"award-info":[{"award-number":["APVV-16-0021"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["1\/0199\/17"],"award-info":[{"award-number":["1\/0199\/17"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Utilization of liquid biopsy in the management of cancerous diseases is becoming more attractive. This method can overcome typical limitations of tissue biopsies, especially invasiveness, no repeatability, and the inability to monitor responses to medication during treatment as well as condition during follow-up. Liquid biopsy also provides greater possibility of early prediction of cancer presence. Corpus uteri mesenchymal tumors are comprised of benign variants, which are mostly leiomyomas, but also a heterogenous group of malignant sarcomas. Pre-surgical differentiation between these tumors is very difficult and the final description of tumor characteristics usually requires excision and histological examination. The leiomyomas and malignant leiomyosarcomas are especially difficult to distinguish and can, therefore, be easily misdiagnosed. Because of the very aggressive character of sarcomas, liquid biopsy based on early diagnosis and differentiation of these tumors would be extremely helpful. Moreover, after excision of the tumor, liquid biopsy can contribute to an increased knowledge of sarcoma behavior at the molecular level, especially on the formation of metastases which is still not well understood. In this review, we summarize the most important knowledge of mesenchymal uterine tumors, the possibilities and benefits of liquid biopsy utilization, the types of molecules and cells that can be analyzed with this approach, and the possibility of their isolation and capture. Finally, we review the typical abnormalities of leiomyomas and sarcomas that can be searched and analyzed in liquid biopsy samples with the final aim to pre-surgically differentiate between benign and malignant mesenchymal tumors.<\/jats:p>","DOI":"10.3390\/ijms20153825","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T11:17:47Z","timestamp":1565003867000},"page":"3825","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri"],"prefix":"10.3390","volume":"20","author":[{"given":"Dana","family":"Dvorsk\u00e1","sequence":"first","affiliation":[{"name":"Division of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrieta","family":"\u0160kovierov\u00e1","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"Bran\u00fd","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Hala\u0161ov\u00e1","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Dankov\u00e1","sequence":"additional","affiliation":[{"name":"Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and Pathogenesis of Uterine Leiomyomas: A Review","volume":"111","author":"Flake","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High Cumulative Incidence of Uterine Leiomyoma in Black and White Women: Ultrasound Evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine Leiomyoma: Available Medical Treatments and New Possible Therapeutic Options","volume":"98","author":"Islam","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","article-title":"Surveillance, Epidemiology, and End Results Analysis of 2677 Cases of Uterine Sarcoma 1989\u20131999","volume":"93","author":"Brooks","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5152\/dir.2014.14053","article-title":"Uterine Sarcomas: Clinical Presentation and MRI Features","volume":"21","author":"Santos","year":"2015","journal-title":"Diagnostic Interv. Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/mco.2013.124","article-title":"The Biology of Uterine Sarcomas: A Review and Update","volume":"1","author":"Kobayashi","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/IJWH.S117754","article-title":"Uterine Sarcoma \u2013 Current Perspectives","volume":"9","author":"Benson","year":"2017","journal-title":"Int. J. Womens. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2214\/AJR.14.13946","article-title":"Review of Leiomyoma Variants","volume":"205","author":"Arleo","year":"2015","journal-title":"Am. J. Roentgenol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated Data Analysis Reveals Uterine Leiomyoma Subtypes with Distinct Driver Pathways and Biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/cncr.28900","article-title":"Molecular Analyses of 6 Different Types of Uterine Smooth Muscle Tumors: Emphasis in Atypical Leiomyoma","volume":"120","author":"Zhang","year":"2014","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.ijgo.2015.06.006","article-title":"Uterine Sarcomas","volume":"131","author":"Prat","year":"2015","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3892\/ol.2015.4062","article-title":"A Clinicopathological Study of Atypical Leiomyomas: Benign Variant Leiomyoma or Smooth-Muscle Tumor of Uncertain Malignant Potential","volume":"11","author":"Kalogiannidis","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0000000000000909","article-title":"Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-Recognized: A Low Threshold for ALK Immunohistochemistry Is Required","volume":"41","author":"Pickett","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","first-page":"543","article-title":"Malignant Transformation of Uterine Leiomyomata","volume":"29","author":"Indraccolo","year":"2008","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_15","first-page":"84","article-title":"Leiomyosarcoma: A Rare Malignant Transformation of a Uterine Leiomyoma","volume":"36","author":"Patacchiola","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"27595","DOI":"10.18632\/oncotarget.25137","article-title":"Malignant Transformation of Uterine Leiomyoma to Myxoid Leiomyosarcoma after Morcellation Associated with ALK rearrangement and Loss of 14q","volume":"9","author":"Holzmann","year":"2018","journal-title":"Oncotarget"},{"key":"ref_17","first-page":"1","article-title":"Uterine Sarcoma: Histology, Classification and Prognosis","volume":"4","author":"Blythe","year":"2008","journal-title":"Gynecology and Obstetrics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.critrevonc.2014.10.013","article-title":"Rare Uterine Cancer: Carcinosarcomas. Review from Histology to Treatment","volume":"94","author":"Artioli","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine Sarcomas: A Review","volume":"116","author":"Prat","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2017.00066","DOI":"10.4293\/JSLS.2017.00066","article-title":"Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids","volume":"22","author":"Chen","year":"2018","journal-title":"JSLS J. Soc. Laparoendosc. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/AOG.0b013e3182888478","article-title":"Surgical Management of Leiomyomas for Fertility or Uterine Preservation","volume":"121","author":"Falcone","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.fertnstert.2003.08.043","article-title":"Estrogen and Progesterone Receptor Expression in Patients with Uterine Smooth Muscle Tumors","volume":"81","author":"Bodner","year":"2004","journal-title":"Fertil. Steril."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/bjc.2013.2","article-title":"The Etiology of Uterine Sarcomas: A Pooled Analysis of the Epidemiology of Endometrial Cancer Consortium","volume":"108","author":"Felix","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcrpr.2017.10.002","article-title":"Leiomyosarcoma: A Rare Soft Tissue Cancer Arising from Multiple Organs","volume":"5","author":"Singh","year":"2018","journal-title":"J. Cancer Res. Pract."},{"key":"ref_25","unstructured":"Mas, A., and Sim\u00f3n, C. (2018). Molecular Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas. Biol. Reprod., 1\u20139."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/cas.13613","article-title":"Molecular Biomarkers for Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma","volume":"109","author":"Tsuyoshi","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_27","first-page":"146","article-title":"A Case of Cancer in Which Cells Similar to Those in the Tumours Were Seen in the Blood after Death","volume":"14","author":"Ashworth","year":"1869","journal-title":"Aust. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid Biopsy: Monitoring Cancer-Genetics in the Blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lodewijk, I., Due\u00f1as, M., Rubio, C., Munera-Maravilla, E., Segovia, C., Bernardini, A., Teijeira, A., Paramio, J.M., and Su\u00e1rez-Cabrera, C. (2018). Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092514"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Perakis, S., and Speicher, M.R. (2017). Emerging Concepts in Liquid Biopsies. BMC Med., 15.","DOI":"10.1186\/s12916-017-0840-6"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"175883591879463","DOI":"10.1177\/1758835918794630","article-title":"Liquid Biopsy of Cancer: A Multimodal Diagnostic Tool in Clinical Oncology","volume":"10","author":"Palmirotta","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The Impact of Uterine Leiomyomas: A National Survey of Affected Women","volume":"209","author":"Borah","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.21037\/tlcr.2016.08.06","article-title":"Pros: Can Tissue Biopsy Be Replaced by Liquid Biopsy?","volume":"5","author":"Hofman","year":"2016","journal-title":"Transl. lung cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Arneth, B. (2018). Update on the Types and Usage of Liquid Biopsies in the Clinical Setting: A Systematic Review. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4433-3"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/ERC-15-0369","article-title":"Methylated Circulating Tumor DNA in Blood: Power in Cancer Prognosis and Response","volume":"23","author":"Warton","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1039\/C8LC00100F","article-title":"Circulating Tumor DNA and Liquid Biopsy: Opportunities, Challenges, and Recent Advances in Detection Technologies","volume":"18","author":"Gorgannezhad","year":"2018","journal-title":"Lab Chip"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid Biopsies Come of Age: Towards Implementation of Circulating Tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"40737","DOI":"10.1038\/srep40737","article-title":"Individualised Multiplexed Circulating Tumour DNA Assays for Monitoring of Tumour Presence in Patients after Colorectal Cancer Surgery","volume":"7","author":"Ng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yang, N., Li, Y., Liu, Z., Qin, H., Du, D., Cao, X., Cao, X., Li, J., Li, D., and Jiang, B. (2018). The Characteristics of CtDNA Reveal the High Complexity in Matching the Corresponding Tumor Tissues. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4199-7"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-018-0875-0","article-title":"Heterogeneous Mutation Pattern in Tumor Tissue and Circulating Tumor DNA Warrants Parallel NGS Panel Testing","volume":"17","author":"Guo","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_41","first-page":"1","article-title":"Mutation Detection Using Plasma Circulating Tumor DNA (CtDNA) in a Cohort of Asymptomatic Adults at Increased Risk for Cancer","volume":"9","author":"Kammesheidt","year":"2018","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1535-7163.MCT-17-1015","article-title":"Correlation of Somatic Genomic Alterations Between Tissue Genomics and CtDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers","volume":"17","author":"Toor","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-Free Nucleic Acids as Biomarkers in Cancer Patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1373\/clinchem.2016.260331","article-title":"Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?","volume":"62","author":"Leung","year":"2016","journal-title":"Clin. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e00292","DOI":"10.1042\/BSR20150180","article-title":"Diagnostic Technologies for Circulating Tumour Cells and Exosomes","volume":"36","author":"Shao","year":"2016","journal-title":"Biosci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/PPO.0000000000000310","article-title":"Circulating Tumor Cells","volume":"24","author":"Agarwal","year":"2018","journal-title":"Cancer J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/prca.201400114","article-title":"Exosomes in Bodily Fluids Are a Highly Stable Resource of Disease Biomarkers","volume":"9","author":"Boukouris","year":"2015","journal-title":"Proteom.-Clin. Appl."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1304816","DOI":"10.1155\/2017\/1304816","article-title":"No Significant Difference between Plasma MiRNAs and Plasma-Derived Exosomal MiRNAs from Healthy People","volume":"2017","author":"Tian","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kawaguchi, T., Komatsu, S., Ichikawa, D., Tsujiura, M., Takeshita, H., Hirajima, S., Miyamae, M., Okajima, W., Ohashi, T., and Imamura, T. (2016). Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091459"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"De Souza, M.F., Kuasne, H., de Camargo Barros-Filho, M., Cili\u00e3o, H.L., Marchi, F.A., Fuganti, P.E., Paschoal, A.R., Rogatto, S.R., and de Syllos C\u00f3lus, I.M. (2017). Circulating MRNAs and MiRNAs as Candidate Markers for the Diagnosis and Prognosis of Prostate Cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184094"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating Mutant DNA to Assess Tumor Dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbcan.2006.10.001","article-title":"Circulating Nucleic Acids (CNAs) and Cancer\u2014A Survey","volume":"1775","author":"Fleischhacker","year":"2007","journal-title":"Biochim. Biophys. Acta-Rev. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.gene.2016.06.033","article-title":"Evaluation and Comparison of in Vitro Degradation Kinetics of DNA in Serum, Urine and Saliva: A Qualitative Study","volume":"590","author":"Yao","year":"2016","journal-title":"Gene"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000345182","article-title":"Circulating Tumor Cells in Lung Cancer","volume":"56","author":"Young","year":"2012","journal-title":"Acta Cytol."},{"key":"ref_55","first-page":"2527","article-title":"Clinical Significance of Circulating Tumor Cells via Combined Whole Exome Sequencing in Early Stage Cancer Screening: A Case Report","volume":"16","author":"Su","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fonc.2018.00066","article-title":"The Origin and Functions of Exosomes in Cancer","volume":"8","author":"Rajagopal","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/jcp.25387","article-title":"Quantification of Exosomes","volume":"232","author":"Koritzinsky","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in Exosome Isolation Techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00281-010-0234-8","article-title":"Exosomes\/Microvesicles: Mediators of Cancer-Associated Immunosuppressive Microenvironments","volume":"33","author":"Taylor","year":"2011","journal-title":"Semin. Immunopathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1440131","DOI":"10.1080\/20013078.2018.1440131","article-title":"Extracellular Vesicles as a Platform for Membrane-Associated Therapeutic Protein Delivery","volume":"7","author":"Yang","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1039\/C5AN00688K","article-title":"Exosomes: Improved Methods to Characterize Their Morphology, RNA Content, and Surface Protein Biomarkers","volume":"140","author":"Wu","year":"2015","journal-title":"Analyst"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nbt0416-359","article-title":"Exosome Cancer Diagnostic Reaches Market","volume":"34","author":"Sheridan","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"492","DOI":"10.21037\/tlcr.2016.10.03","article-title":"Methylation Analyses in Liquid Biopsy","volume":"5","author":"Lissa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/bjc.2014.104","article-title":"Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Cell-Free DNA Provides Prognostic Information in Non-Small Cell Lung Cancer","volume":"110","author":"Balgkouranidou","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13353-013-0149-x","article-title":"Detection of MGMT, RASSF1A, P15INK4B, and P14ARF Promoter Methylation in Circulating Tumor-Derived DNA of Central Nervous System Cancer Patients","volume":"54","author":"Paluszczak","year":"2013","journal-title":"J. Appl. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13148-016-0261-y","article-title":"Aberrant Methylation of Cell-Free Circulating DNA in Plasma Predicts Poor Outcome in Diffuse Large B Cell Lymphoma","volume":"8","author":"Kristensen","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.csbj.2018.10.002","article-title":"Techniques of Using Circulating Tumor DNA as a Liquid Biopsy Component in Cancer Management","volume":"16","author":"Elazezy","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2147\/CMAR.S161382","article-title":"Diagnostic Accuracy of Droplet Digital PCR for Detection of EGFR T790M Mutation in Circulating Tumor DNA","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2017.06.030","article-title":"Circulating Tumour DNA (CtDNA) as a Liquid Biopsy for Melanoma","volume":"404","author":"Calapre","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13073-017-0500-7","article-title":"The Potential of Circulating Tumor DNA Methylation Analysis for the Early Detection and Management of Ovarian Cancer","volume":"9","author":"Widschwendter","year":"2017","journal-title":"Genome Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Le, A., Szaumkessel, M., Tan, T., Thiery, J.-P., Thompson, E., and Dobrovic, A. (2018). DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum\u2014Implications for the Choice of Circulating Tumour DNA Methylation Markers. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092553"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nmat4997","article-title":"Circulating Tumour DNA Methylation Markers for Diagnosis and Prognosis of Hepatocellular Carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Nat. Mater."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/bioinformatics\/btx505","article-title":"BSviewer: A Genotype-Preserving, Nucleotide-Level Visualizer for Bisulfite Sequencing Data","volume":"33","author":"Sun","year":"2017","journal-title":"Bioinformatics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1373\/clinchem.2013.212274","article-title":"Noninvasive Prenatal Methylomic Analysis by Genomewide Bisulfite Sequencing of Maternal Plasma DNA","volume":"59","author":"Lun","year":"2013","journal-title":"Clin. Chem."},{"key":"ref_75","first-page":"71","article-title":"Detection of Aberrant P16 Methylation in the Plasma and Serum of Liver Cancer Patients","volume":"59","author":"Wong","year":"1999","journal-title":"Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5732\/cjc.010.10239","article-title":"MUC1-Positive Circulating Tumor Cells and MUC1 Protein Predict Chemotherapeutic Efficacy in the Treatment of Metastatic Breast Cancer","volume":"30","author":"Cheng","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","article-title":"ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance","volume":"60","author":"Kuhlmann","year":"2014","journal-title":"Clin. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cca.2013.01.018","article-title":"A Negative Selection System PowerMag for Effective Leukocyte Depletion and Enhanced Detection of EpCAM Positive and Negative Circulating Tumor Cells","volume":"419","author":"Lin","year":"2013","journal-title":"Clin. Chim. Acta."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/CMAR.S141623","article-title":"Detection of Circulating Tumor Cells in Liquid Biopsy from Ewing Sarcoma Patients","volume":"10","author":"Benini","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1373\/clinchem.2014.228122","article-title":"Circulating Tumor Cell Enumeration with a Combination of Epithelial Cell Adhesion Molecule-and Cell-Surface Vimentin-Based Methods for Monitoring Breast Cancer Therapeutic Response","volume":"61","author":"Satelli","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"78965","DOI":"10.18632\/oncotarget.20697","article-title":"Size-Based Detection of Sarcoma Circulating Tumor Cells and Cell Clusters","volume":"8","author":"Hayashi","year":"2017","journal-title":"Oncotarget"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/bit.26787","article-title":"Filter-Based Isolation, Enrichment, and Characterization of Circulating Tumor Cells","volume":"115","author":"Khetani","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/adhm.201200046","article-title":"Microfluidic Cell Sorter (\u03bc FCS) for On-Chip Capture and Analysis of Single Cells","volume":"1","author":"Chung","year":"2012","journal-title":"Adv. Healthc. Mater."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nmeth.3404","article-title":"A Microfluidic Device for Label-Free, Physical Capture of Circulating Tumor Cell Clusters","volume":"12","author":"Sarioglu","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"141ra92","DOI":"10.1126\/scitranslmed.3003747","article-title":"Ultrasensitive Clinical Enumeration of Rare Cells Ex Vivo Using a Micro-Hall Detector","volume":"4","author":"Issadore","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1039\/C4LC00869C","article-title":"A Multi-Scale PDMS Fabrication Strategy to Bridge the Size Mismatch between Integrated Circuits and Microfluidics","volume":"14","author":"Muluneh","year":"2014","journal-title":"Lab Chip"},{"key":"ref_87","first-page":"43","article-title":"Structure and Function Analysis in Circulating Tumor Cells: Using Nanotechnology to Study Nuclear Size in Prostate Cancer","volume":"6","author":"Yao","year":"2018","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1753495X16652007","article-title":"Noninvasive Prenatal Testing for Aneuploidy Using Cell-Free DNA \u2013 New Implications for Maternal Health","volume":"9","author":"Hui","year":"2016","journal-title":"Obstet. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1373\/clinchem.2017.277517","article-title":"Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing","volume":"64","author":"Dharajiya","year":"2018","journal-title":"Clin. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/pd.4973","article-title":"Prenatal CfDNA Screening Results Indicative of Maternal Neoplasm: Survey of Current Practice and Management Needs","volume":"37","author":"Giles","year":"2017","journal-title":"Prenat. Diagn."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1200\/JCO.2018.36.15_suppl.11565","article-title":"Identification of Leiomyosarcoma Circulating Tumor DNA through Ultra-Low Passage Whole Genome Sequencing and Correlation with Tumor Burden: A Pilot Experience","volume":"36","author":"Hemming","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00235","article-title":"Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease","volume":"3","author":"Hemming","year":"2019","journal-title":"JCO Precis. Oncol."},{"key":"ref_93","first-page":"1461","article-title":"Extracellular MicroRNA in Liquid Biopsy: Applicability in Cancer Diagnosis and Prevention","volume":"6","author":"Izzotti","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2018.10.003","article-title":"Liquid Biopsy in Ovarian Cancer: The Potential of Circulating MiRNAs and Exosomes","volume":"205","author":"Giannopoulou","year":"2019","journal-title":"Transl. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"24778","DOI":"10.18632\/oncotarget.8352","article-title":"DNA Promoter Hypermethylation in Nipple Fluid: A Potential Tool for Early Breast Cancer Detection","volume":"7","author":"Moelans","year":"2016","journal-title":"Oncotarget"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Takashima, Y., Kawaguchi, A., Iwadate, Y., Hondoh, H., Fukai, J., Kajiwara, K., Hayano, A., and Yamanaka, R. (2019). MicroRNA Signature Constituted of MiR-30d, MiR-93, and MiR-181b Is a Promising Prognostic Marker in Primary Central Nervous System Lymphoma. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210400"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"36","DOI":"10.20517\/2394-4722.2017.58","article-title":"Circulating MicroRNAs as a Liquid Biopsy: A next-Generation Clinical Biomarker for Diagnosis of Gastric Cancer","volume":"4","author":"Komatsu","year":"2018","journal-title":"J. Cancer Metastasis Treat."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/pcmedi\/pbz003","article-title":"Applying Circulating Tumor DNA Methylation in the Diagnosis of Lung Cancer","volume":"2","author":"Li","year":"2019","journal-title":"Precis. Clin. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/annonc\/mdv272","article-title":"Digital PCR Quantification of MGMT Methylation Refines Prediction of Clinical Benefit from Alkylating Agents in Glioblastoma and Metastatic Colorectal Cancer","volume":"26","author":"Barault","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_100","first-page":"2812","article-title":"Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumour DNA from Cerebrospinal Fluid","volume":"24","author":"Mayor","year":"2018","journal-title":"Author Manuscr. Publ. OnlineFirst"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-17-1140","article-title":"Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer","volume":"23","author":"Vandekerkhove","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Cimadamore, A., Gasparrini, S., Massari, F., Santoni, M., Cheng, L., Lopez-Beltran, A., Scarpelli, M., and Montironi, R. (2019). Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy. Cancers., 11.","DOI":"10.3390\/cancers11020196"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tranon.2015.08.004","article-title":"Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology","volume":"8","author":"Kirkizlar","year":"2015","journal-title":"Transl. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00401-015-1399-y","article-title":"Liquid Biopsies in Patients with Diffuse Glioma","volume":"129","author":"Best","year":"2015","journal-title":"Acta Neuropathologica."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Miller, A.M., Shah, R.H., Pentsova, E.I., Pourmaleki, M., Briggs, S., Distefano, N., Zheng, Y., Skakodub, A., Mehta, S.A., and Campos, C. (2019). Tracking Tumour Evolution in Glioma through Liquid Biopsies of Cerebrospinal Fluid. Nature, 654\u2013658.","DOI":"10.1038\/s41586-019-0882-3"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Yin, C.Q., Yuan, C.H., Qu, Z., Guan, Q., Chen, H., and Wang, F.B. (2016). Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers. Dis. Markers.","DOI":"10.1155\/2016\/1427849"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","article-title":"An Overview of MicroRNAs","volume":"87","author":"Hammond","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1582-4934.2007.00207.x","article-title":"Differential Expression of MicroRNAs in Myometrium and Leiomyomas and Regulation by Ovarian Steroids","volume":"12","author":"Pan","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"ref_109","first-page":"45","article-title":"Differential Expression of MiRNAs in Uterine Leiomyoma and Adjacent Myometrium of Different Races","volume":"2","author":"Liu","year":"2015","journal-title":"Am J Clin Exp Obstet Gynecol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/gcc.20415","article-title":"A Micro-RNA Signature Associated with Race, Tumor Size, and Target Gene Activity in Human Uterine Leiomyomas","volume":"46","author":"Wang","year":"2007","journal-title":"Genes, Chromosom. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12958-016-0180-y","article-title":"MicroRNA-15b Regulates Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) Expression in Human Uterine Leiomyoma","volume":"14","author":"Guan","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/febs.12074","article-title":"MicroRNA-15a Promotes Neuroblastoma Migration by Targeting Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) and Regulating Matrix Metalloproteinase-9 Expression","volume":"280","author":"Xin","year":"2013","journal-title":"FEBS J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1158\/0008-5472.CAN-08-2635","article-title":"Reck Negatively Regulates Matrix Metalloproteinase-9 Transcription","volume":"69","author":"Takagi","year":"2009","journal-title":"Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1261\/rna.051177.115","article-title":"Systematic Analysis of the Hmga2 3\u2032 UTR Identifies Many Independent Regulatory Sequences and a Novel Interaction between Distal Sites","volume":"21","author":"Fogarty","year":"2015","journal-title":"RNA"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"De Almeida, B.C., Garcia, N., Maffazioli, G., Dos Anjos, L.G., Baracat, E.C., and Carvalho, K.C. (2018). Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010052"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42047-019-0032-0","article-title":"MiRNAs 144-3p, 34a-5p, and 206 Are a Useful Signature for Distinguishing Uterine Leiomyosarcoma from Other Smooth Muscle Tumors","volume":"2","author":"Schiavon","year":"2019","journal-title":"Surg. Exp. Pathol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2353\/ajpath.2010.091150","article-title":"A Differentiation-Based MicroRNA Signature Identifies Leiomyosarcoma as a Mesenchymal Stem Cell-Related Malignancy","volume":"177","author":"Danielson","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s13277-013-0748-5","article-title":"MicroRNAs in Uterine Sarcomas and Mixed Epithelial\u2013Mesenchymal Uterine Tumors: A Preliminary Report","volume":"34","author":"Kowalewska","year":"2013","journal-title":"Tumor Biol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Gonzalez dos Anjos, L., de Almeida, B., Gomes de Almeida, T., Mour\u00e3o Lavorato Rocha, A., De Nardo Maffazioli, G., Soares, F., Werneck da Cunha, I., Chada Baracat, E., Candido Carvalho, K., and Gonzalez dos Anjos, L. (2018). Could MiRNA Signatures Be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?. Cancers (Basel), 10.","DOI":"10.3390\/cancers10090315"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ygyno.2016.01.001","article-title":"Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma Have Unique MiRNA Signatures","volume":"140","author":"Ravid","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Zavadil, J., Ye, H., Liu, Z., Wu, J., Lee, P., Hernando, E., Soteropoulos, P., Toruner, G.A., and Wei, J.-J. (2010). Profiling and Functional Analyses of MicroRNAs and Their Target Gene Products in Human Uterine Leiomyomas. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012362"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.fertnstert.2007.05.074","article-title":"Differential Expression of MicroRNA Species in Human Uterine Leiomyoma versus Normal Myometrium","volume":"89","author":"Marsh","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygeno.2012.03.003","article-title":"Characterization of the Uterine Leiomyoma MicroRNAome by Deep Sequencing","volume":"99","author":"Georgieva","year":"2012","journal-title":"Genomics"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.fertnstert.2016.05.001","article-title":"Decreased Expression of MicroRNA-29 Family in Leiomyoma Contributes to Increased Major Fibrillar Collagen Production","volume":"106","author":"Marsh","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1210\/me.2012-1075","article-title":"MiR-93\/106b and Their Host Gene, MCM7, Are Differentially Expressed in Leiomyomas and Functionally Target F3 and IL-8","volume":"26","author":"Chuang","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13402-016-0306-4","article-title":"MiR-152 down-Regulation Is Associated with MET up-Regulation in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma","volume":"40","author":"Pazzaglia","year":"2017","journal-title":"Cell. Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1530\/ERC-12-0007","article-title":"MiR-200c Is Aberrantly Expressed in Leiomyomas in an Ethnic-Dependent Manner and Targets ZEBs, VEGFA, TIMP2, and FBLN5","volume":"19","author":"Chuang","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2015.02.004","article-title":"Effects of MiRNA-197 Overexpression on Proliferation, Apoptosis and Migration in Levonorgestrel Treated Uterine Leiomyoma Cells","volume":"71","author":"Wu","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas","volume":"334","author":"Makinen","year":"2011","journal-title":"Science"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate Hydratase\u2013Deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archdermatol.2008.517","article-title":"Association of Germline Mutations in the Fumarate Hydratase Gene and Uterine Fibroids in Women with Hereditary Leiomyomatosis and Renal Cell Cancer","volume":"144","author":"Stewart","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijc.21798","article-title":"Analysis of Fumarate Hydratase Mutations in a Population-Based Series of Early Onset Uterine Leiomyosarcoma Patients","volume":"119","author":"Kiuru","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/bjc.2012.428","article-title":"Somatic MED12 Mutations in Uterine Leiomyosarcoma and Colorectal Cancer","volume":"107","author":"Kilpivaara","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"M\u00e4kinen, N., Aavikko, M., Heikkinen, T., Taipale, M., Taipale, J., Koivisto-Korander, R., B\u00fctzow, R., and Vahteristo, P. (2016). Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12. PLOS Genet., 12.","DOI":"10.1371\/journal.pgen.1005850"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/hum.2017.218","article-title":"The First Approved Gene Therapy Product for Cancer Ad-P53 (Gendicine): 12 Years in the Clinic","volume":"29","author":"Zhang","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cjp2.11","article-title":"Loss of ATRX and DAXX Expression Identifies Poor Prognosis for Smooth Muscle Tumours of Uncertain Malignant Potential and Early Stage Uterine Leiomyosarcoma","volume":"1","author":"Slatter","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/modpathol.2017.56","article-title":"Leiomyoma with Bizarre Nuclei: A Morphological, Immunohistochemical and Molecular Analysis of 31 Cases","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1101\/gad.282145.116","article-title":"RB1: A Prototype Tumor Suppressor and an Enigma","volume":"30","author":"Dyson","year":"2016","journal-title":"Genes Dev."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"89848","DOI":"10.18632\/oncotarget.21163","article-title":"Rapid, Ultra Low Coverage Copy Number Profiling of Cell-Free DNA as a Precision Oncology Screening Strategy","volume":"8","author":"Hovelson","year":"2017","journal-title":"Oncotarget"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00285","article-title":"Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors","volume":"2018","author":"Klega","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cancergencyto.2010.06.002","article-title":"Fusion of HMGA2 to COG5 in Uterine Leiomyoma","volume":"202","author":"Velagaleti","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2005.07.017","article-title":"Array Comparative Genomic Hybridization Analysis of Uterine Leiomyosarcoma","volume":"99","author":"CHO","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1073\/pnas.101132598","article-title":"Frequent Fusion of the JAZF1 and JJAZ1 Genes in Endometrial Stromal Tumors","volume":"98","author":"Koontz","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_144","first-page":"19","article-title":"Allelic Knockout of Novel Splice Variants of Human Recombination Repair Gene RAD51B in t(12;14) Uterine Leiomyomas","volume":"59","author":"Schoenmakers","year":"1999","journal-title":"Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/onc.2009.381","article-title":"Discovery of Molecular Subtypes in Leiomyosarcoma through Integrative Molecular Profiling","volume":"29","author":"Beck","year":"2010","journal-title":"Oncogene"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1158\/0008-5472.CAN-05-2485","article-title":"Consistent Rearrangement of Chromosomal Band 6p21 with Generation of Fusion Genes JAZF1\/PHF1 and EPC1\/PHF1 in Endometrial Stromal Sarcoma","volume":"66","author":"Micci","year":"2006","journal-title":"Cancer Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(02)00592-7","article-title":"Updates on the Cytogenetics and Molecular Genetics of Bone and Soft Tissue Tumors: Alveolar Soft Part Sarcoma","volume":"136","author":"Sandberg","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-4608(99)00054-0","article-title":"Expression of HMGIY in Three Uterine Leiomyomata with Complex Rearrangements of Chromosome 6","volume":"114","author":"Sornberger","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2014.01.030","article-title":"MEAF6\/PHF1 Is a Recurrent Gene Fusion in Endometrial Stromal Sarcoma","volume":"347","author":"Micci","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1158\/0008-5472.CAN-04-0050","article-title":"Uterine Leiomyomata with t (10; 17) Disrupt the Histone Acetyltransferase MORF","volume":"64","author":"Moore","year":"2004","journal-title":"Cancer Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/ijc.28440","article-title":"Identification of a Novel, Recurrent MBTD1-CXorf67 Fusion in Low-Grade Endometrial Stromal Sarcoma","volume":"134","author":"Dewaele","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/gcc.22057","article-title":"Fusion of the ZC3H7B and BCOR Genes in Endometrial Stromal Sarcomas Carrying an X;22-Translocation","volume":"52","author":"Panagopoulos","year":"2013","journal-title":"Genes, Chromosom. Cancer"},{"key":"ref_153","first-page":"9","article-title":"Alport Syndrome and Diffuse Leiomyomatosis. Clinical Aspects, Pathology, Molecular Biology and Extracellular Matrix Studies. A Synthesis","volume":"21","author":"Cruz","year":"2000","journal-title":"Nephrologie"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2559.2008.03022.x","article-title":"Cytogenetic Analyses of Two New Cases of Endometrial Stromal Sarcoma\u2014Non-Random Reciprocal Translocation t(10;17)(Q22;P13) Correlates with Fibrous ESS","volume":"52","author":"Regauer","year":"2008","journal-title":"Histopathology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cancergencyto.2009.03.011","article-title":"Characterization of a Recurrent t (1; 2)(P36; P24) in Human Uterine Leiomyoma","volume":"193","author":"Sweers","year":"2009","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2005.07.017","article-title":"Array Comparative Genomic Hybridization Analysis of Uterine Leiomyosarcoma","volume":"99","author":"Cho","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"48769","DOI":"10.18632\/oncotarget.17953","article-title":"Genetic Heterogeneity in Leiomyomas of Deep Soft Tissue","volume":"8","author":"Panagopoulos","year":"2017","journal-title":"Oncotarget"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.013","article-title":"Genetic Aberrations in Soft Tissue Leiomyosarcoma","volume":"275","author":"Yang","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.humpath.2014.05.010","article-title":"Recurrent Chromosomal Aberrations in Intravenous Leiomyomatosis of the Uterus: High-Resolution Array Comparative Genomic Hybridization Study","volume":"45","author":"Buza","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/gcc.1125","article-title":"Genomic Alterations in Uterine Leiomyosarcomas: Potential Markers for Clinical Diagnosis and Prognosis","volume":"31","author":"Hu","year":"2001","journal-title":"Genes, Chromosom. Cancer"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-4608(92)90443-C","article-title":"Interphase Cytogenetic Analysis of Karyotypically Normal Uterine Leiomyoma Excludes Undetected Trisomy 12","volume":"63","author":"Vanni","year":"2003","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Gai, W., and Sun, K. (2019). Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy. Genes., 10.","DOI":"10.3390\/genes10010032"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Maekawa, R., Sato, S., Yamagata, Y., Asada, H., Tamura, I., Lee, L., Okada, M., Tamura, H., Takaki, E., and Nakai, A. (2013). Genome-Wide DNA Methylation Analysis Reveals a Potential Mechanism for the Pathogenesis and Development of Uterine Leiomyomas. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066632"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4161\/cc.20538","article-title":"DAPk Silencing by DNA Methylation Conveys Resistance to Anti EGFR Drugs in Lung Cancer Cells","volume":"11","author":"Kimchi","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ygyno.2010.11.018","article-title":"Hypermethylated DAPK in Serum DNA of Women with Uterine Leiomyoma Is a Biomarker Not Restricted to Cancer","volume":"121","author":"Diebolder","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/molehr\/gan045","article-title":"Potential Link between Estrogen Receptor-\u03b1 Gene Hypomethylation and Uterine Fibroid Formation","volume":"14","author":"Asada","year":"2008","journal-title":"Mol. Hum. Reprod."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/gyno.1999.5662","article-title":"Assessment of Hypermethylated DNA in Two Promoter Regions of the Estrogen Receptor \u03b1 Gene in Human Endometrial Diseases","volume":"76","author":"Hori","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1262\/jrd.2013-095","article-title":"Potential Mechanisms of Aberrant DNA Hypomethylation on the x Chromosome in Uterine Leiomyomas","volume":"60","author":"Sato","year":"2014","journal-title":"J. Reprod. Dev."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Navarro, A., Yin, P., Monsivais, D., Lin, S.M., Du, P., Wei, J.-J., and Bulun, S.E. (2012). Genome-Wide DNA Methylation Indicates Silencing of Tumor Suppressor Genes in Uterine Leiomyoma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033284"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"30652","DOI":"10.1038\/srep30652","article-title":"Identification of Uterine Leiomyoma-Specific Marker Genes Based on DNA Methylation and Their Clinical Application","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/path.1419","article-title":"Mechanisms of Inactivation of Thep16INK4a Gene in Leiomyosarcoma of Soft Tissue: Decreased P16 Expression Correlates with Promoter Methylation and Poor Prognosis","volume":"201","author":"Kawaguchi","year":"2003","journal-title":"J. Pathol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1158\/0008-5472.CAN-09-2543","article-title":"A Role for BRCA1 in Uterine Leiomyosarcoma","volume":"69","author":"Xing","year":"2009","journal-title":"Cancer Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/412068","article-title":"Genomic, Epigenomic, and Transcriptomic Profiling towards Identifying Omics Features and Specific Biomarkers That Distinguish Uterine Leiomyosarcoma and Leiomyoma at Molecular Levels","volume":"2015","author":"Miyata","year":"2015","journal-title":"Sarcoma"},{"key":"ref_174","first-page":"4435","article-title":"Abstract 4435: Genome-Scale DNA Methylation Changes Delineate Uterine Leiomyoma Subgroups","volume":"Volume 76","author":"Kaasinen","year":"2016","journal-title":"Molecular and Cellular Biology, Genetics"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3892\/ol.2012.771","article-title":"The Promoter Methylation and Expression of the O6-Methylguanine-DNA Methyltransferase Gene in Uterine Sarcoma and Carcinosarcoma","volume":"4","author":"Bujko","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ijc.20707","article-title":"Alterations of Cancer-Related Genes in Soft Tissue Sarcomas: Hypermethylation OfRASSF1A Is Frequently Detected in Leiomyosarcoma and Associated with Poor Prognosis in Sarcoma","volume":"114","author":"Seidel","year":"2005","journal-title":"Int. J. Cancer"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/modpathol.3800502","article-title":"DNA Hypermethylation Status of Multiple Genes in Soft Tissue Sarcomas","volume":"19","author":"Kawaguchi","year":"2006","journal-title":"Mod. Pathol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-2143(03)00007-6","article-title":"Differential Gene Expression in Uterine Leiomyoma","volume":"141","author":"Skubitz","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/humrep\/deh698","article-title":"Gene Expression Studies Provide Clues to the Pathogenesis of Uterine Leiomyoma: New Evidence and a Systematic Review","volume":"20","author":"Arslan","year":"2005","journal-title":"Hum. Reprod."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.fertnstert.2004.01.047","article-title":"Molecular Characterization of Uterine Fibroids and Its Implication for Underlying Mechanisms of Pathogenesis","volume":"82","author":"Hoffman","year":"2004","journal-title":"Fertil. Steril."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/cncr.11586","article-title":"Differential Gene Expression in Leiomyosarcoma","volume":"98","author":"Skubitz","year":"2003","journal-title":"Cancer"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","article-title":"Uterine Leiomyosarcoma: A Review of the Literature and Update on Management Options","volume":"151","author":"Roberts","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.humpath.2013.11.003","article-title":"Gene Expression Signatures of Primary and Metastatic Uterine Leiomyosarcoma","volume":"45","author":"Davidson","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2012.11.021","article-title":"Gene Expression Signatures Differentiate Uterine Endometrial Stromal Sarcoma from Leiomyosarcoma","volume":"128","author":"Davidson","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.csbj.2016.05.004","article-title":"Circulating Biomarkers to Monitor Cancer Progression and Treatment","volume":"14","author":"Rapisuwon","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.18632\/oncotarget.24140","article-title":"Challenges in Using Liquid Biopsies for Gene Expression Profiling","volume":"9","author":"Porras","year":"2018","journal-title":"Oncotarget"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1373\/clinchem.2016.260299","article-title":"Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells","volume":"62","author":"Gorges","year":"2016","journal-title":"Clin. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"44623","DOI":"10.18632\/oncotarget.5977","article-title":"EpCAM Based Capture Detects and Recovers Circulating Tumor Cells from All Subtypes of Breast Cancer except Claudin-Low","volume":"6","author":"Ring","year":"2015","journal-title":"Oncotarget"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Prendergast, E.N., De Souza Fonseca, M.A., Dezem, F.S., Lester, J., Karlan, B.Y., Noushmehr, H., Lin, X., and Lawrenson, K. (2018). Optimizing Exosomal RNA Isolation for RNA-Seq Analyses of Archival Sera Specimens. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196913"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.18632\/oncotarget.2349","article-title":"Integrated Analysis of Long Noncoding RNAs and MRNAs Reveals Their Potential Roles in the Pathogenesis of Uterine Leiomyomas","volume":"5","author":"Guo","year":"2014","journal-title":"Oncotarget"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/s41388-019-0808-4","article-title":"H19 LncRNA Identified as a Master Regulator of Genes That Drive Uterine Leiomyomas","volume":"38","author":"Cao","year":"2019","journal-title":"Oncogene"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/bjc.2017.361","article-title":"Global Metabolomic Profiling of Uterine Leiomyomas","volume":"117","author":"Heinonen","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/molehr\/gam040","article-title":"Retinoic Acid Pathway Genes Show Significantly Altered Expression in Uterine Fibroids When Compared with Normal Myometrium","volume":"13","author":"Zaitseva","year":"2007","journal-title":"MHR Basic Sci. Reprod. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2008.03207.x","article-title":"Retinoic Acid Treatment of Human Leiomyoma Cells Transformed the Cell Phenotype to One Strongly Resembling Myometrial Cells","volume":"69","author":"Malik","year":"2008","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e5325","DOI":"10.1097\/MD.0000000000005325","article-title":"Association between Uterine Leiomyoma and Metabolic Syndrome in Parous Premenopausal Women","volume":"95","author":"Tak","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/pmic.201500514","article-title":"High-Grade Sarcoma Diagnosis and Prognosis: Biomarker Discovery by Mass Spectrometry Imaging","volume":"16","author":"Lou","year":"2016","journal-title":"Proteomics"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s13361-016-1544-4","article-title":"Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging","volume":"28","author":"Lou","year":"2017","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.4100","article-title":"Discordant Noninvasive Prenatal Testing Results in a Patient Subsequently Diagnosed with Metastatic Disease","volume":"33","author":"Osborne","year":"2013","journal-title":"Prenat. Diagn."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"10549","DOI":"10.18632\/oncotarget.24278","article-title":"Circulating Tumour-Derived DNA in Metastatic Soft Tissue Sarcoma","volume":"9","author":"Eastley","year":"2018","journal-title":"Oncotarget"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1158\/1078-0432.CCR-17-3704","article-title":"Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma","volume":"24","author":"Przybyl","year":"2018","journal-title":"Clin. Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/15\/3825\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:08:46Z","timestamp":1760188126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/15\/3825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":200,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["ijms20153825"],"URL":"https:\/\/doi.org\/10.3390\/ijms20153825","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]}}}